Advances in Cardiomyopathies

Introduction: II Florence Meeting on Advances in Cardiomyopathies.- The Classification of Cardiomyopathies.- Hypertrophic Cardiomyopathy.- The Clinical Significance of Genetic Testing in Familial Hypertrophic Cardiomyopathy.- The Italian Multicentric Study on Hypertrophic Cardiomyopathy: I. Natural History and Clinical Course of Unselected Patients.- The Italian Multicentric Study on Hypertrophic Cardiomyopathy: II. Prognostic Assessment in Symptomatic Patients.- Detection and Clinical Consequences of Myocardial Ischemia and Reduced Coronary Reserve.- Identification and Management of High Risk Patients with Hypertrophic Cardiomyopathy.- Hypertrophic Cardiomyopathy and Sudden Death in the Young: a Pathologist’s View.- The Clinicopathologic Spectrum of Hypertrophic Cardiomiopathy. The Experience of the Italian Heart Transplant Program.- Medical Treatment Options in Hypertrophic Cardiomyopathy.- DDD Pacing in Hypertrophic Cardiomyopathy: State of the Art.- Indications and Outcome of Cardiac Surgery for Severely Symptomatic Patients with Hypertrophic Obstructive Cardiomyopathy.- Dilated Cardiomyopathy: Etiology, Pathophysiology and Clinical Data.- Genetic Basis of Dilated Cardiomyopathy.- Virus Infection in Cardiomyopathies: Brief Overview, Recent Advances.- Organ-Specific Cardiac Autoantibodies in Dilated Cardiomyopathy: Pathogenetic Implications.- Inflammatory Cardiomyopathy: Diagnostic and Therapeutical Options.- Mitochondrial DNA Mutations and Cardiomyopathies.- Pathophysiologic Role of Coronary Microcirculatory Impairment in Dilated Cardiomyopathy.- Myocardial Catecholamines and Inotropic Response in Heart Muscle Disease.- Molecular Biology of Heart Failure.- Dilated Cardiomyopathy: Does Etiological Heterogeneity Portend Clinical Heterogeneity?.- Recent Advances in Etiopathogenesis of Dilated Cardiomyopathy: Which Relevance for the Clinical Cardiologist?.- The Italian Multicentric Study: Natural History of Dilated Cardiomyopathy.- Mildly Dilated Cardiomyopathy.- Dilated Cardiomyopathy: Treatment.- Immunosuppressive Treatment for Inflammatory Dilated Cardiomyopathy (Myocarditis).- Prevention of Sudden Death in Patients with Dilated Cardiomyopathy.- Medical Treatment of Heart Failure: Problems in Dilated Cardiomyopathy.- Treatment of Dilated Cardiomyopathies with ?-adrenergic Blocking Agents.- The role of ?-Blockers in the Management of Heart Failure: Results of Controlled Trials.- Controversial Issues on ?-Blocker Treatment: Has Metoprolol an Additive Effect to Conventional Medical Treatment in Heart Failure Due to Dilated Cardiomyopathy?.- ?-Blockers for Heart Failure: Practical Issues.- DDD Pacing in Dilated Cardiomyopathy.- End-Stage Heart Failure and Timing of Heart Transplantation.- Cardiomyoplasty: Surgical Therapy for Ischemic and Idiopathic Dilated Cardiomyopathies.- Left Ventricular Assist Device as Bridge to Transplantation.